The Role of Autologous Stem Cell Transplantation in the Treatment of Diffuse Large B-cell Lymphoma in the Era of CAR-T Cell Therapy
Abstract. For many years now and based on the results of the PARMA trial, relapsed Diffuse Large B-cell Lymphoma (DLBCL) is treated with salvage combination cytotoxic chemotherapy (most often platinum-based) followed by high dose myeloablative chemotherapy and autologous stem cell transplantation (a...
| Autori principali: | , |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Wiley
2019-12-01
|
| Serie: | HemaSphere |
| Accesso online: | http://journals.lww.com/10.1097/HS9.0000000000000295 |